Hangzhou Realy Tech Co., Ltd. was founded in 2015. It is a headquartered and globally operated In-Vitro Diagnostic company, specialized in point-of-care tests and Immunoassay system for more than 5 years. The company sits on a 6000 square meters science park and is equipped with state-of-the-art R&D and production facilities.
Our broad product lines consist of Rapid Test, Drugs Test Readers, POCT Readers, and Automatic Chemiluminescence Immunoassay system machine. All these systems are compatible with the detection of nearly 150 kinds of immune markers, inspection items covering cardiovascular diseases, infectious diseases, hepatitis disease, diabetes, health checkups and maternity Branch and other fields. It is not only suitable for rapid diagnosis of critical illnesses in large and medium-sized hospitals and labs, but also suitable for comprehensive immunological quantitative analysis of small and medium-sized hospitals and labs.
The company established by the food and drug administration certification of clean workshop and nearly 700 ㎡ workshop. The current daily output of 100000 doses, with quantitative in vitro diagnostic kits and clinical tester machine production capacity, in addition to our company own brand products, we also provide OEM service for customers, to visit system, OTC market, ministry of public security and epidemic prevention departments provide a variety of specifications of the products. The product sells in distant markets domestic and foreign markets.
Novel Coronavirus (SARS-Cov-2) Antigen Rapid Test Cassette
(update clinical report 10.2020)
Clinical sensitivity = 96,17 %
Clinical specificity = ＞ 99,9 %
No Crossreaction with other Coronavirus like MERS, 229E, OC43, NL63, HKU1
or Influenza A, B